[1] 张春叶, 胡宇华, 周荣睿, 等. 唾液腺腺样囊性癌细胞系中5个抑癌基因甲基化及其表达[J].中国口腔颌面外科杂志,2010,8(1):55-59. [2] Bitarte N, Bandres E, Boni V, et al. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells [J]. Stem Cells, 2011, 29(11): 1661-1671. [3] Feng B, Wang R, Chen LB. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1 [J]. Cancer Lett, 2012, 317(2): 184-191. [4] Maeno A, Terada N, Uegaki M, et al. Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions [J]. Prostate, 2014, 74(16): 1604-1612. [5] Zhang X, Zhang Y, Yang J, et al. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma [J]. Cancer Gene Ther, 2015, 22(10): 475-480. [6] Abd Raboh NM, Hakim SA. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas [J]. Int J Clin Exp Pathol, 2015, 8(8): 9214-9222. [7] Stárek I, Salzman R, Kucerová L, et al. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma [J]. Pathol Res Pract, 2015, 211(10): 759-765. [8] Li J, Huang H, Sun L, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor[J]. Clin Cancer Res, 2009, 15(12): 3998-4008. [9] Liu H, Li W, Chen C, et al. MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma [J].Tumour Biol, 2015, 36(8): 6313-6319. [10] Sun L, Yao Y, Liu B, et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 [J]. Oncogene, 2012, 31(4): 432-445. [11] Kutanzi KR, Yurchenko OV, Beland FA, et al. MicroRNA-mediated drug resistance in breast cancer[J]. Clin Epigenetics, 2011, 2(2): 171-185 [12] Kovalchuk O, Filkowski J, Meservy J, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin [J]. Mol Cancer Ther, 2008, 7(7): 2152-2159. [13] Zhang Y, Huang W, Ran Y, et al. miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3 [J]. Tumour Biol, 2015 36(11): 8309-8316. |